Cystic Fibrosis Canada featured on Employee of the Week
FDA approves KALYDECO (VX-770), the first medicine to treat the underlying cause of cystic fibrosis
Pseudomonas Team Grant Awarded to Dr. Valerie Waters
Cystic Fibrosis Canada applauds today’s announcement by the Government of Canada directing $30 million in funding to improve Canada’s healthcare system
Cystic Fibrosis Canada applauds the announcement by the Council of Federation concerning the establishment of a Health Care Innovation Working Group
Appointment Notice
CARSTAR has launched an iPhone app called “Unhappen My Accident”.
Dr. Dao Nguyen (McGill University) has shown in laboratory experiments that resistance to antibiotics develops when bacteria become starved for nutrients during infection.
The 25th Annual North American Cystic Fibrosis Conference (NACFC) is taking place in Anaheim, California from November 3-5 and is the largest gathering of cystic fibrosis professionals in the world.
STRIVE research team, including Canadian CF researchers Drs. Felix Ratjen and Liz Tullis, published ground-breaking results in the November 3, 2011, edition of The New England Journal of Medicine.
This study also confirmed a link between Nedd4L and increased transport of sodium across a membrane
Drs. Chris Mody, Liz Tullis and Shawn Aaron, along with Cystic Fibrosis Canada's President Debra Berlet, discuss our revised infection control policy
The campaigns provide an opportunity to talk about cystic fibrosis, your personal story, the importance of high quality CF care in Canada, the work of Cystic Fibrosis Canada and our major successes to date...
Québec cystic fibrosis (CF) families now have provincial formulary access to TOBI* PODHALER*, a fast and convenient inhaled therapy for CF patients aged six and over.
Dr. Daniela Rotin (The Hospital for Sick Children, Toronto) and her research team have developed a new breed of mice that exhibit cystic fibrosis-like lung disease.
Céline Dion and René Angélil recently received Cystic Fibrosis Canada’s Hall of Fame award at a ceremony in Las Vegas.
A Canadian expedition to Easter Island, 1964, led to the discovery of the antibiotic rapamycin ...
The Common Drug Review (CDR) has recommended that Cayston® be listed on provincial formularies with criteria.
Voluntary Recall of Oral B mouthwash by Procter & Gamble
A Courageous New Step: The CF Technology Initiative
Cystic Fibrosis Canada welcomes B.C., Saskatchewan and Ontario’s leadership in the pursuit of a national health care innovation agenda
Nearly $40,000 raised for 2011 Great Strides™ walk
Dr. Lap-Chee Tsui, OC, awarded for Excellence in Health Research
Students across Canada fundraise in support of Cystic Fibrosis Canada
7th annual Great Strides™: Taking Steps to Cure Cystic Fibrosis walk raises more than $2.95 million in support of cystic fibrosis cause
Join Cystic Fibrosis Canada at the 7th annual Great Strides™: Taking steps to cure cystic fibrosis walk
Severity of cystic fibrosis may be determined by presence of newly-identified modifier genes
Each week in Canada two children are diagnosed with cystic fibrosis (CF) and one person dies from the disease.
Donation boxes for Cystic Fibrosis Canada will be displayed at LCBO checkout counters until May 31
Cystic Fibrosis Canada aims to reach greater heights in fight against cystic fibrosis
The University of British Columbia, in partnership with the Canadian Cystic Fibrosis Foundation (CCFF) and the Centre for Drug Research and Development (CDRD), today launches the Cystic Fibrosis Technology Initiative (CFTI) to advance Canadian techno
Top fundraiser for 2010 Great Strides™ walk wins trip to Disney World for her family
London woman to chair national cystic fibrosis advocacy group
walk raises more than $2.5 million in support of cystic fibrosis cause
Long-time volunteer appointed President of the Canadian Cystic Fibrosis Foundation
Researchers have discovered a genetic risk factor for severe liver disease in children and adults with cystic fibrosis.